Filing Details

Accession Number:
0001179110-15-001059
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-20 16:10:05
Reporting Period:
2015-01-16
Filing Date:
2015-01-20
Accepted Time:
2015-01-20 16:10:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600843 Carla Flakne 51 Sawyer Road, Suite 200
Waltham MA 02453
Vp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-07 380 $0.00 3,011 No 5 G Direct
Common Stock Acquisiton 2015-01-16 10,000 $23.15 13,252 No 4 M Direct
Common Stock Disposition 2015-01-16 10,000 $42.45 3,252 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-01-16 10,000 $0.00 10,000 $23.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 462 Indirect See Footnote
Footnotes
  1. Includes 248 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2014.
  2. The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
  3. Includes 241 shares acquired under the Alere Inc. Employee Stock Purchase Plan on December 31, 2014.
  4. The price reported is a weighted average price. These shares were sold in approximately 68 separate transactions at prices ranging from $41.81 to $42.82, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was effected.
  5. Option vested in four equal installments on 12/14/06, 12/14/07, 12/14/08 and 12/14/09.
  6. This derivative security does not have a price.
  7. These securities are owned by the 2012 Flakne Family Trust, for which the reporting person & her spouse are the trustees.